Movianto News

Future market: logistics for medical cannabis

HAPA pharm, which develops, manufactures and distributes medical cannabis products, has commissioned Movianto with storage, distribution and fulfilment tasks in Germany.

– HAPA pharm commissions Movianto: location in Kist to become import hub and distribution centre for cannabis products
– Logistics specialist organises Germany-wide distribution and takes over fulfilment up to invoicing
– Narcotics handling: high demands on safety and 100 per cent transparent documentation

(Neunkirchen) The Dortmund-based company HAPA pharm, which develops, manufactures and distributes medical cannabis products, has commissioned Movianto, a service provider specialising in logistics for the healthcare industry, with storage, distribution and fulfilment tasks in Germany. “The storage and handling of such products is a future market with high demands and strongly increasing demand, for which we have specifically prepared ourselves,” says Dennis Spamer, Managing Director of Movianto Germany. “As a logistics provider for healthcare products, we can ideally contribute our know-how and our special storage options here.” According to a report by the ARD magazine Plusminus, the demand for cannabis for medical use has increased rapidly in recent years. In 2020, for example, 9.4 tonnes were imported into Germany, almost 20 times as much as in 2017.

Because cannabis belongs to the opiates, the special conditions of the Narcotics Act regarding safety and documentation apply to these products. “Narcotics are kept in a completely separate area in the warehouse,” says Spamer. “Thick safe doors seal off the narcotics warehouse, the access points to the area are specially secured and directly connected to the police. The logistics service provider must be able to provide information at any time about where and how much of which substance is and what was delivered to whom and when.”

In addition, cannabis products are stored and transported at temperatures between 15 and 25 degrees Celsius. “We can offer all this at our location in Würzburg-Kist, which serves as an import hub and distribution centre for HAPA pharm.” In the process, Movianto employees report the receipt of the goods to the Federal Opium Agency, and draw a sample from each batch when it is stored, which is then examined by an external laboratory. Once the batches have been released, Movianto can start picking the goods on an order-by-order basis and organise transport to pharmacies or wholesalers. The authority also receives a semi-annual report on the stocks, which Movianto checks daily. This semi-annual report includes all movements of narcotics. “In addition, HAPA pharm also uses our “Order to Cash” service,” says Spamer. Here Movianto takes over the entire order processing up to the invoice to the end customer recipient.

About Movianto

Movianto is part of the Walden Group, founded in 1951. With its one-stop-shop service for the distribution of healthcare products, Walden is now Europe’s market leader for logistics and transport in the pharmaceutical and healthcare industry. Movianto aims to be the preferred European logistics partner for this industry and to offer the best service for pharmaceutical as well as biotechnical products, for medical technology as well as for diagnostics. Along the logistics chain of such products, Movianto as an outsourcing partner offers, for example, warehouse logistics and transport (also temperature-controlled), but also complete solutions such as order to cash or purchasing and procurement services. Movianto’s international clients benefit from a pan-European network, a wide range of pharmaceutical logistics, unique industry know-how and standardised processes in accordance with quality standards such as ISO 9001 and ISO 13485. Movianto employs more than 3,200 people, has space for more than 630,000 pallets in its network of 23 company-owned logistics centres in eleven European countries and operates throughout Europe.

About Walden

Walden is a family-owned group of companies consisting of six different operating companies with two different areas of expertise: express transport and healthcare/pharmaceuticals. Walden has 70 years of experience in the healthcare field and is today Europe’s market leader with its own logistics centres in 12 countries, more than 6,000 employees and a turnover of 2.1 billion euros in 2022. The group is today led by Stéphane Baudry, the grandson of the founder. With numerous investments, Walden has developed, among other things, digital solutions to increase the safety and quality of its subsidiaries’ processes. The company is committed to the values of integrity, quality and innovation in the service of healthcare.

For more information, please contact

Laure Murat ­| Marketing and Communication at Walden Group